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Project Description
The purpose of this capstone project is to evaluate provider knowledge, attitudes, and behaviors
around lung cancer screening in Maine. To evaluate these elements, a survey will be developed
and administered to primary care physicians in Maine through three physician specialty societies.
The survey will be developed keeping existing literature and previous studies of a similar nature
in mind. This survey is being developed in collaboration with the Center for Outcomes Research
and Evaluation (CORE), a branch of Maine Medical Center Research Institute. The EvidenceBased Public Health Framework will be used to outline and ground this capstone project.

Background
Lung cancer is a significant problem in the United States, where it represents the second most
common cancer and most common cause of cancer death (Weiss et al., 2016). As of 2014,
Maine, specifically, had the sixth highest lung cancer incidence rate in the nation, with 72.1 out
of every 100,000 people developing lung cancer (Centers for Disease Control and Prevention,
2017). Compared with most other states, Maine citizens are at a greater risk for developing lung
cancer and this emphasizes the need for early detection and treatment.

Low-dose CT (LDCT) scans are a relatively new lung cancer screening test that lower the risk of
mortality for patients at high risk of developing lung cancer. The risk of mortality is lowered
because LDCT detects potentially cancerous nodules earlier than other screening methods. An
important event in lung cancer screening history was the National Lung Screening Trial (NLST)
which released its findings in 2011 (National Cancer Institute, 2014). This study compared chest
x-ray and LDCT screening methods among current smokers, and former heavy smokers (greater
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than or equal to 30 pack years). This study found that those receiving LDCT screening had a 15
to 20 percent lower chance of dying from lung cancer. Since the findings of this study were
released LDCT screening has been an evidence-based recommendation by the United States
Preventive Services Task Force (USPSTF) and is considered a covered service by the Centers for
Medicare and Medicaid Services (CMS) (Duong et al., 2017).

To determine which Maine residents get screened, it is important to understand providers’
screening behaviors and gauge their level of knowledge and beliefs regarding the existing
screening guidelines.

CORE is leading the Maine Lung Cancer Coalition (MLCC), a statewide, multi- institution
initiative aimed at promoting prevention and early detection of lung cancer, and ultimately
reducing morbidity and mortality from this disease in Maine. MLCC works to educate all Maine
people, including patients and healthcare professionals alike, about evidence-based lung cancer
prevention and screening practices as well as developing and getting involved with programs to
increase access to evidence-based lung cancer prevention, screening, and treatment services. To
inform future efforts in promoting LDCT screening, the MLCC decided to develop and
administer a survey to understand primary care physicians’ knowledge, attitudes, and practices
regarding lung cancer screening in Maine. This survey aims to collect data on how much
screening is currently being performed and what the barriers to screening may be for some
providers. These barriers could include personal bias, access to equipment, lack of personnel to
perform screening, or even lack of knowledge about how to conduct lung cancer screening,
among others.
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A survey was selected as the appropriate method of measurement because it allows assessment
of a larger number of providers and enables quantitative analyses of the frequencies of various
knowledge, attitudes, and practices, and of the factors associated with these outcomes. A survey
also allows sampling of providers from the entire state of Maine to participate.

Project Framework
The framework used to outline and ground this project is the evidence-based public health
framework. This is a commonly used and well recognized framework. It is composed of seven
cycling steps including community assessment, quantifying the issue, developing a concise
statement of the issue, determining what it known using scientific literature, developing and
prioritizing program and policy options, developing an action plan and implementing
interventions, and evaluating the program or policy (Association of State and Territorial Health
Officials, 2018). This project will specifically involve assessing the community by reaching out
to providers with our survey. This survey will help to quantify the issue and develop a concise
statement of the issue, specifically in Maine. This survey will be developed considering existing
research that has been done around lung cancer and lung cancer screening. Ultimately,
development of program and policy options, as well as development of an action plan and
intervention implementation will occur after analysis of the survey findings is complete.

Literature Review
There are various guidelines around lung cancer screening and not all providers follow the same
guidelines (American Academy of Family Physicians, 2016; American Cancer Society, 2013;
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American College of Radiology, 2015; Centers for Medicare & Medicaid Services, 2015;
National Comprehensive Cancer Network, 2014; U.S. Preventive Services Task Force, 2013;
Wiener, 2015) For this reason, literature surrounding lung cancer screening is not comprehensive
and there are some gaps. Providers represent a wealth of knowledge, and understanding their
views and behaviors about lung cancer screening may better help the medical field to more
effectively address the problem of lung cancer deaths. Consistent themes in the literature include
limitations in provider knowledge of screening guidelines, varying attitudes and behaviors
around lung cancer screening, and limitations in the feasibility of implementing LDCT lung
cancer screening.

Provider Knowledge
Knowledge of lung cancer screening and the screening guidelines is mentioned numerous times
in the literature. Most primary care providers need more education regarding guidelines for
LDCT screening, including insurance coverage, cost, and the frequency of false positive test
results (Lewis et al., 2015). Triplette et al. (2018) found that decision aids are helpful knowledge
facilitators for providers. A study done in the Stanford Health Care system found that education
for providers around LDCT screening can increase the accuracy and efficacy of screening
(Duong et al., 2017). They also found that four out of five providers were interested in learning
more about LDCT screening (Duong et al., 2017). In a study by Rajupet et al. (2017) primary
care physician (PCP) and specialist attitudes about LDCT were compared. They found that
PCP’s are less comfortable with LDCT screening than specialists and more education around
lung cancer screening may help to improve PCP’s comfort regarding screening (Rajupet et al.,
2017). Kanodra et al. (2016) determined in their study that providers are receptive to learning
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about LDCT screening, and that more effort is needed to improve knowledge of guidelines,
especially regarding patient eligibility criteria.

Informed/Shared Decision-Making Skills
Education around how to have shared decision- making conversations with patients is another key
piece in the screening process (Lewis et al., 2015). Hoffman et al. (2017) noted that providers
were not aware of NLST findings or existing guideline recommendations. They also mentioned
that lung cancer screening programs need to educate providers to support informed decisionmaking and ensure high-quality screening (Hoffman et al., 2017).

Provider Attitudes
Findings regarding provider attitudes towards lung cancer screening vary in the existing
literature. Most notably, the 95 percent false-positive rate was a concern for providers once they
were made familiar with NLST findings (Hoffman et al., 2017). Additional studies are needed to
identify the benefits and challenges of using shared decision-making tools when counseling
about LDCT screening, and to determine the effect of these interventions on provider behavior
and ordering of lung cancer screening (Rajupet et al., 2017). How provider attitudes impact the
way they practice medicine in general is a theme that frequently comes up in the literature as a
future direction for research. Triplette et al. (2017) noted that attitudes and barriers by specialty
should be looked into to determine optimal screening implementation across provider types.
Rajupet et al. (2017) also mentioned that as implementation of lung cancer screening programs
become more common, more research around provider attitudes and barriers to screening would
bring to light any limitations of the NLST trial on which lung cancer screening recommendations
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are largely based.

Stigma
There is scant existing research regarding provider stigma regarding lung cancer patients and
screening. This gap is an important problem for future research given that many other clinical
practices have been shown to be affected by personal bias, even if this bias is not recognized.
According to Latner et al., a prejudice against overweight people is not widely recognized by
society as those outside of this group do not question their bias and those in the group feel that
the bias is justified, and internalize these beliefs as truths. This leads one to question if lung
cancer beliefs are similar, meaning that the population agrees that lung cancer is their fault, thus
justifying these beliefs. Survey measures to assess stigma have been utilized in obesity and HIV
research. Latner et al. (2008) published a study “Weighing obesity stigma: the relative strength
of different forms of bias.” They included the Universal Measure of Bias – Fat Scale, which
includes items that determine the bias their study participants felt toward obese people. The
Universal Measure of Bias items are used to measure bias around weight, sexuality, and religion.
Items specifically addressing bias need to be included in lung cancer screening surveys to
understand attitudes toward smokers and those with lung cancer.

Another study performed by Christian S. Crandall (1994), “Prejudice Against Fat People:
Ideology and Self-Interest,” included the development of the Anti-Fat Attitudes questionnaire to
test explicit weight stigma. These items were similar to those included in the Universal Measure
of Bias survey and probe providers’ personal beliefs. Interestingly, Crandall found that people
felt more comfortable expressing a bias toward obesity than a racial bias. This finding suggests
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some biases may be more acceptable in society than others.

Access
Research written by Lewis et al., (2015) documented some of the differences between use of
LDCT and chest x-ray screening. Frequently providers reported using chest x-ray instead of
LDCT because of lack of insurance coverage and the financial burden of LCDT for patients
(Lewis et al., 2015). The authors found most patients do not want to pay out of pocket for lung
cancer screening (Lewis et al., 2015).

Available resources in a given community may also be a barrier for some providers when it
comes to LDCT screening and smoking cessation services (Richards, White, & Caraballo, 2014).
Providers report a lack of time and resources to address lung cancer screening in their clinical
practice (Triplette et al., 2017). Similarly, lack of time and resources are issues that providers in
Kanodra et al.’s (2016) study mentioned as barriers to implementing more shared decisionmaking and smoking cessation services.

Project Objectives
Plans to advance this research include:
development of the provider survey,
pilot testing of the survey,
IRB approval to distribute the survey (both USM and MMCRI approval),
distribution of the survey to primary care physicians in Maine, and
reporting findings
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This capstone focuses on the first two steps (e.g. developing and pilot testing the survey with
providers).

The specific research questions addressed by the survey include:
What are the lung cancer screening practices of providers in Maine?
How knowledgeable are providers about lung cancer screening?
How confident are providers that they can implement lung cancer screening?
To what extent do providers acknowledge stigmatizing attitudes towards patients who
smoke, and do these attitudes relate to providers’ self-reported screening attitudes and
behaviors?

Sample Development
Three physicians’ societies in Maine have agreed to allow administration of the provider survey
with their members. These three societies are American College of Physicians, Maine Chapter
(433 members), American Academy of Family Physicians, Maine chapter (530 members), and
Maine Primary Care Association (219 members). Maine Primary Care Association has roughly
110 medical doctors, and many of these members are also members of the other 2 societies, so
there is some overlap.

The target audience for this research is primary care physic ians, specifically internal medicine
and family medicine providers. Ultimately, this survey will help us better understand Maine
provider’s knowledge and beliefs around lung cancer screening. In addition, it is our hope that
we might be able to understand how a provider’s beliefs might influence their screening
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behaviors. Once there is an understanding about how behaviors and beliefs vary, there will be
more clarity about how to intervene to encourage providers to effectively use lung cancer
screening strategies, and how best to share information regarding screening.

Methods
Survey Development
A team of four including the author and CORE staff worked together to develop the survey
targeting members of the participating associations (above). Items used in existing provider
surveys about lung cancer screening were considered, as were stigma-related items from HIV
and obesity research questionnaires. The team then edited selected items to make the attitudes
section of the survey more robust. Several drafts of the survey were edited by the team and
interested partners before pilot testing took place. Details regarding development of the
questionnaire are reported below under findings.

Development of the survey questionnaire began after review of the literature to understand the
lung cancer screening research surveys that had been conducted previously. Once existing
surveys had been evaluated, the research team pulled specific items that could elicit responses
relevant to the research questions.

Pilot Development
One of the specialty societies required that the survey be approved by their national branch
before allowing their members to take it. This was to ensure that the survey was not too long and
would not cause any distress to the providers who would be taking it. Each society also had to

10

LUNG CANCER SCREENING PROVIDER SURVEY
approve a pre-written letter for approval or write their own before submitting the project to IRB
for review. Another necessary piece before IRB submission was confirming funding from Maine
Cancer Foundation (MCF). This raised additional questions as MCF needed clear
communication about how exactly the stipend for each society was determined and what each
society was using the funding for. To clarify this information the application for funding was
delayed by negotiation between CORE and MCF for several months.

Cognitive Testing
To assess the comprehensibility of survey items, individual cognitive testing interviews were
completed with three medical professionals who are representative of the survey population. The
interviews included a medical resident, who would not be receiving this survey, and two Internal
Medicine physicians employed at Maine Medical Center, who would also not be receiving this
survey through any of the medical societies. Each cognitive interview was conducted using a
paper-and-pencil version of the survey rather than the online version that will be used for
participants.

Online Survey Programming
The survey was loaded into REDCap, a HIPAA-compliant online survey platform widely used in
biomedical research. REDCap was selected as the platform due to its ease of inputting items,
ease of access for the participants, and personalized links that could be sent directly to each
participant email account. Although this was a relatively easy process, the question and response
formatting and branching for question skip patterns required for some of the items proved to be
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very time consuming. We estimate that the 50-item questionnaire required about 10 hours for
entry and editing.

IRB Review of Pilot
Letters of support from each association and approval from their national offices, confirmed
external funding, and a completed IRB application were necessary before submitting to the
MMC IRB. Because time was limited for this capstone project, the short submission to IRB
through the University of Southern Maine was used to determine that pilot testing of the survey
was not research and, therefore, did not require a full IRB.

Findings
Survey Development
Upon reflection of the survey items the team selected, the group identified four domains in which
to sort items: knowledge, attitudes, practices/behaviors, and provider characteristics. Classifying
items in these categories was intended to ensure that only necessary and relevant items would be
included in the survey.

One domain that had not been included in previous lung cancer screening surveys was the
potential role of stigma in providers’ attitudes towards screening and treating smokers and lung
cancer patients. To develop items for this domain, the research team searched the literature for
stigma items in HIV and obesity surveys. Some of these items were altered to fit for lung cancer
screening survey. The team also developed stigma items of their own to get at unique dimension
of stigma that might unintentionally play a role in lung cancer screening practices.
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Cognitive Testing
Cognitive testing is a method of identifying problems in survey items that may impede their
understandability or reliability. This method uses individual interviews in which respondents
provide feedback on survey items, and identify difficulties in understanding. One of our pilot
testers was a new doctor, fresh out of residency. He felt that he might have more knowledge
about lung cancer screening than most doctors in Maine due to his interest in preventive care.
Another doctor specialized in geriatrics and had less knowledge and experience with lung cancer
screening but background experience with pilot testing surveys of her own, so provided very
thorough feedback. The third doctor was an internal medicine teaching physician who no longer
practices clinical medicine.

Our first provider to test the survey completed the 50 items in 11 minutes and found the survey
to be mostly easy to answer. However, going through item by item, there was more confusion
than he initially indicated. In particular there were concerns about the language of response
options not appropriately matching the question they belong to. For example, strongly disagree
through strongly agree might be better as strongly discourage through strongly encourage.
Another concern was the need for clarification around some of the language used in the
questionnaire. The most significant finding from this provider was that he felt some of the stigma
items might have been too strongly worded. This meaning that providers might be reluctant to
answer truthfully because their bias regarding lung cancer patients and smokers might become
too clear.
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The second provider, who had more experience as a doctor but knew less about lung cancer
screening, also went through the survey item by item. With her experience in survey research,
she was candid about her thoughts on each item which was helpful as we were interested in
learning what providers taking this survey would think about it. This pilot tester shared many of
the same comments as the first about changing the language of some items and response options.
She made several comments about moving items around to better the flow of the survey. This
tester was excited about the stigma items, but again was concerned about how honest providers
might be when answering them. She presented the idea that instead of asking about the provider
specifically, making the subject “many physicians” might encourage providers to answer more
freely. This way they are not answering about themselves and their beliefs, but their peers.

The third provider mentioned many of the same concerns as the other two, and also felt that
physicians may not be able to provide accurate information on some questions, including the
total number of patients referred for screening in the past. She also pointed out how physicians
may have difficulty providing reliable answers of what they do for their “average” patients
because their patient population is heterogeneous.

Conclusions
Survey development is a complex task and there are many steps and details that need to be
considered throughout the process. One of the most essential parts is finding a time to get all
members of the survey team in one room at the same time. When working with individuals that
have several projects going at once, this can be a challenge, so flexibility is key. Important
considerations and concerns when creating the survey include the length and content. Time
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matters, especially considering the provider population being asked to complete the lung cancer
screening survey. Keeping the items simple and the time commitment to a minimum was
something that the survey development team kept in mind throughout the process. Another
important thing to keep in mind was that this population has taken numerous surveys and they
are intelligent people. They know what the stigma items are getting at and the goal is to make the
provider feel comfortable answering honestly, not to alienate them. This is why selecting and
creating stigma items was especially challenging.

Pilot testing of this survey was extremely helpful to the survey development process. After
having the same four pairs of eyes on the survey for months, having a fresh perspective was
happily welcomed. Language that may be understood by the survey development team did not
always translate to the providers and could make all the difference in how those surveyed will
respond to the item. For this reason, having an outside perspective and understanding of the
survey is beneficial. When there are new items that can have an emotional response, like those
around stigma, it is important to have someone from the potential study population provide
feedback before launching them. The goal of this survey is to receive honest responses that will
help understand where providers stand on the issue of lung cancer screening. If the items are too
intrusive the findings could be skewed. The pilot testers for this survey were enlightening
because they came from difference places in their careers and had different focuses. This allowed
the survey development team to see varied perspectives and hone in on the areas that stood out to
the testers as needing work.
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This survey will be one the first of its kind because it is getting at a provider’s attitudes around
lung cancer screening and the at-risk population. There is hope that if this survey is successful in
Maine, a similar survey could be launched in other states with high lung cancer rates. Despite the
long process and legwork that it has taken to get this survey developed, it has been a worthwhile
learning experience. My knowledge about survey research has increased tremendously and I
have a better idea of what it takes to make a successful and meaningful survey. Survey research
is a complex process and while maneuvering through it, I discovered several things that may be
of help to future students pursuing similar research projects.

Recommendations
1. Timelines are not set in stone. Anticipating completion dates for each piece of the project
helps outline where the project is going. That being said, it is important to keep this
schedule flexible. Things may come up and slow the project down. These include, but
are not limited to, delays submitting and obtaining IRB responses, miscommunication
with a project partner or funder, or unexpected, but necessary, approval from partners
before distribution of the survey.
2. Expect the unexpected. Despite how well a process has been planned out, barriers will
arise. Acknowledge the barrier, assess its significance, and adapt as necessary. Project
partners may want to have a larger say in the survey development or need approval from
their leadership. These may seem like a roadblock at the time, but the more buy in you
can get from your partners, the more successful your survey will be.
3. Use your resources. Questions will certainly come up throughout the survey research
project. Ask your professional counterparts about their experience and how they may
16
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have handled a hurdle that came up in the past. Access the vast literature available at
your fingertips.
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Cognitive Testing Notes
Page 1
Question 1:
Change 12 months to 3 or 4 – some providers may have too many patients to estimate the
number referred for screening in an entire year
Question 2:
Have this question come after eligibility questions – this will help to clarify what
providers know about screening eligibility before asking their approach with eligible
patients
Give an option for those who might not discuss LDCT screening
Discuss down sides of LDCT screening (i.e. false-positives) before getting at this
question
Question 3:
Change the response scale – Strongly encourage-discourage, or reword question: I feel I
should encourage him/her to get screened…
Page 4
Question 1:
Clarify multidisciplinary lung cancer treatment services
Reword “Care processes” to be more clear
Question 5:
Is this question getting at what we want it to? Do we want to emphasize that this question
is intended to mean false-positives?
Page 5
Question 2:
Change RPM to risk calculator on all RPM questions
Page 6
Question 3:
Include SDM in “As a tool for clinicians to help patients decide whether to be screened”
– there was some confusion about the different between option 1 and 3 in this question
Maybe reword to say “As a decision tool for clinicians…” – or “As a patient education
tool...”
Question 4:
Is this question fair? It seems that the question is open to interpretation and that might not
be what we were meaning to do
Potentially include the specific NLST overall risk – give some kind of risk for providers
to better understand the question and answer to the best of their ability
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Page 9
Question 2:
Needs to be completely redone – in particular clarify who plays each role – does PCP
always conduct SDM? If patient navigators are not usually physicians are we going to
skew our results by listing them as a model?
Question 3:
How honest are these physicians going to be? Are some of these items too abrasive?
Think about changing wording to “Many physicians” instead of “I” to make the questions
less personal
Make this the last question of the survey
Consider getting rid of “I would feel more sympathetic toward a person who developed
lung cancer because of a genetic disposition…” item (found on page 10)
Page 10
Question 1:
Clarify which patients in these vignettes are currently smoking (likely all to make it easy
for providers)
Move this set of questions to follow RPM questions
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